If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Marcello Marchetti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Radiosurgery Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Meningioma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Trigeminal Neuralgia Medicine & Life Sciences
Glioblastoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

  • 318 Citations
  • 11 h-Index
  • 33 Article
  • 2 Letter
  • 1 Review article

Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin

on behalf of MPN-K authors, Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalLetter

3 Citations (Scopus)

Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study

Barbui, T., Ghirardi, A., Masciulli, A., Carobbio, A., Palandri, F., Vianelli, N., De Stefano, V., Betti, S., Di Veroli, A., Iurlo, A., Cattaneo, D., Delaini, F., Bonifacio, M., Scaffidi, L., Patriarca, A., Rumi, E., Casetti, I. C., Stephenson, C., Guglielmelli, P., Elli, E. M. & 21 others, Palova, M., Bertolotti, L., Erez, D., Gomez, M., Wille, K., Perez-Encinas, M., Lunghi, F., Angona, A., Fox, M. L., Beggiato, E., Benevolo, G., Carli, G., Cacciola, R., McMullin, M. F., Tieghi, A., Recasens, V., Marchetti, M., Griesshammer, M., Alvarez-Larran, A., Vannucchi, A. M. & Finazzi, G., Jan 1 2019, In : Leukemia. 33, 8, p. 1996-2005

Research output: Contribution to journalArticle

Second Primary Neoplasms
Case-Control Studies
Skin Neoplasms
Neoplasms
Hydroxyurea
8 Citations (Scopus)

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study

GIMEMA, European Research Initiative on CLL (ERIC) & UK CLL forum, Jul 3 2018, In : Haematologica. 103, 7, p. 1209-1217 9 p.

Research output: Contribution to journalArticle

Salvage Therapy
B-Cell Chronic Lymphocytic Leukemia
Survival
Disease-Free Survival
Multivariate Analysis

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study

Cuneo, A., Follows, G., Rigolin, G. M., Piciocchi, A., Tedeschi, A., Trentin, L., Perez, A. M., Coscia, M., Laurenti, L., Musuraca, G., Farina, L., Delgado, A. R., Orlandi, E. M., Galieni, P., Mauro, F. R., Visco, C., Amendola, A., Billio, A., Marasca, R., Chiarenza, A. & 24 others, Meneghini, V., Ilariucci, F., Marchetti, M., Molica, S., Re, F., Gaidano, G., Gonzalez, M., Forconi, F., Ciolli, S., Cortelezzi, A., Montillo, M., Smolej, L., Schuh, A., Eyre, T. A., Kennedy, B., Bowles, K. M., Vignetti, M., De La Serna, J., Moreno, C., Foà, R., Ghia, P., Party, GIMEMA., (ERIC), E. R. I. O. CLL. & forum, UK. CLL., 2018, In : Haematologica. 103, 7, p. 1209-1217 9 p.

Research output: Contribution to journalArticle

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study

Cuneo, A., Follows, G., Rigolin, G. M., Piciocchi, A., Tedeschi, A., Trentin, L., Perez, A. M., Coscia, M., Laurenti, L., Musuraca, G., Farina, L., Delgado, A. R., Orlandi, E. M., Galieni, P., Mauro, F. R., Visco, C., Amendola, A., Billio, A., Marasca, R., Chiarenza, A. & 24 others, Meneghini, V., Ilariucci, F., Marchetti, M., Molica, S., Re, F., Gaidano, G., Gonzalez, M., Forconi, F., Ciolli, S., Cortelezzi, A., Montillo, M., Smolej, L., Schuh, A., Eyre, T. A., Kennedy, B., Bowles, K. M., Vignetti, M., De La Serna, J., Moreno, C., Foà, R., Ghia, P., Party, GIMEMA., (ERIC), E. R. I. O. CLL. & forum, UK. CLL., 2018, In : Haematologica. 103, 7, p. 1209-1217 9 p.

Research output: Contribution to journalArticle